Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Chang Y.-L.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 67 到 72 筆資料,總共 72 筆
< 上一頁
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2021
White matter network disruption and cognitive correlates underlying impaired memory awareness in mild cognitive impairment
Chang Y.-L.; Chao R.-Y.; Hsu Y.-C.; TA-FU CHEN
; YU-LING CHANG
NeuroImage: Clinical
8
8
2020
White matter pathways underlying Chinese semantic and phonological fluency in mild cognitive impairment
Chang Y.-L.; TA-FU CHEN
; YU-LING CHANG
Neuropsychologia
5
4
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G 0-G1 in human hepatocellular carcinoma cells
Wang S.-W.; Pan S.-L.; JIH-HWA GUH
; Chen H.-L.; Huang D.-M.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
47
47
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
Pan S.-L.; JIH-HWA GUH
; Peng C.-Y.; Wang S.-W.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
55
53
2006
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH
; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
39
33
2005
YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells
Huang Y.-T.; Pan S.-L.; JIH-HWA GUH
; Chang Y.-L.; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
Molecular Cancer Therapeutics
45
43